Biomarker test kya hota hai? What does a biomarker test mean?
A biomarker is anything in the body that doctors can measure to learn something about health or disease. A biomarker test checks for it. In cancer, it usually means a test that looks at a gene change, a protein or another feature of the cancer, often on a tissue sample or in blood.
If you have searched for 'biomarker test kya hota hai', the short answer is this: it is a test that gives a clue about the features of a cancer. The result helps doctors understand the cancer better and, in some cases, discuss which treatments may suit it. Names you may see include HER2, EGFR and BRCA. Each is a different biomarker, and each means something different for different cancers. A biomarker test does not give a verdict by itself. Your oncologist decides which tests you need and explains the results in the context of your reports, the stage and your general health.
Is a tumour marker test the same as a biomarker test?
No, although people often search for them as if they were the same. A tumour marker test usually measures a substance in the blood, such as CA 125 or CEA, that may be higher in some cancers. Doctors often follow it over time, alongside scans and examination. A biomarker test, in the sense used for cancer treatment, looks for features of the cancer itself, such as HER2 or EGFR, which can help decide which treatments to discuss.
Put simply, a tumour marker is often a number that may go up or down. A biomarker result is often a type or a yes-or-no answer, such as positive or negative.
The words overlap, because a tumour marker is also a kind of biomarker. That is why reports and websites can confuse the two. For details on tumour markers, see the tumour marker guide on this site. Your oncologist can tell you which kind of test you had and what it is used for.
Is a biomarker test the same as a genetic test?
Not always. Some biomarker tests look at the cancer itself, for example gene changes found only in the tumour cells. Other tests look at genes you were born with, using a blood or saliva sample. These are often called genetic or germline tests.
BRCA is a good example. A BRCA change can be looked for in the tumour or in your inherited genes, and the two tests answer different questions. A tumour result is mostly about the cancer and its treatment options. An inherited result may also matter for relatives, because families share genes. Not every biomarker is a gene. Some are proteins, such as HER2, and some are substances in the blood. So 'genetic test' describes only part of the picture. If your oncologist suggests a genetic test, ask what it is for, who will explain the result, and whether family members may need advice. Some hospitals have genetic counsellors who can help with this. Your oncologist decides what is needed.
Which cancer tests have families often not heard of?
Families often know blood tests and scans, but may not have heard of tests that examine the cancer's own features. Examples include PD-L1, a protein test sometimes used when immunotherapy is discussed; MSI or MMR testing, which looks at how tumour cells repair their genes; and next-generation sequencing, or NGS, which checks many genes in one go. Another is a liquid biopsy, a blood test that looks for tiny pieces of tumour material.
Which of these, if any, apply to you depends on the cancer type, the stage and your oncologist's view. Some are used for only a few cancers, and some may not be offered in every hospital.
OncoVOIS shows tests commonly mentioned in guidelines, from a reviewed list, matched to your reports and labelled as something to discuss. It does not recommend any test. If one catches your eye, ask your oncologist whether it applies to your case, and what the answer would change.
Does a biomarker test tell me if I have cancer?
Usually not. For most people, a biomarker test is done after a cancer has already been found, usually after a biopsy. It tells doctors more about that cancer. It is not the test that finds out whether cancer is present.
A diagnosis normally comes from a combination of the doctor's examination, scans and a biopsy, which is a small sample of tissue looked at under a microscope. Some blood markers are also measured, but a single result cannot confirm or rule out cancer, and other conditions can change them too. Because of this, no one should decide anything from a biomarker result alone, and a result should not be used to diagnose yourself or a family member. If you are worried about symptoms, see a doctor. If something feels urgent, such as sudden severe pain or heavy bleeding, contact your hospital or call 112 (ambulance 108) and do not wait for an app or a test result. Your oncologist explains what each test is for.
A biomarker word in my report is confusing. What can I do?
It helps to stay calm. Many report words look alarming but have a simple meaning. Look up the word, then ask your oncologist what it means for you.
In OncoVOIS, each report gets a summary in plain words, and hard words are explained in a plain-words glossary. You can tap a term to see two or three plain sentences about it. You can also use Ask: type or speak a question, and answers can be read aloud. Answers use your own reports and reviewed medical pages, and anything general is labelled as general information. The app says when it is not sure. If the word is a test name such as HER2 or EGFR, the explanation tells you what the test looks at in general. It cannot tell you what a result means for your own treatment. That is for your oncologist. Write the word down and take it to the visit.
How long does a biomarker test result take?
It varies. Some results come back sooner and others take longer, particularly if the sample must be sent to a specialised laboratory. The time depends on the test, the laboratory and the hospital, so no single answer fits everyone.
Biomarker tests are often done on tissue kept from a biopsy or surgery, and the laboratory may run them after the main biopsy report is ready. So the biomarker result can arrive as a separate report, later than the first one. Some tests also need more steps in the laboratory than a routine blood test. The best way to know is to ask the hospital or the laboratory when to expect it and who will tell you. Ask your oncologist whether treatment discussions will wait for the result, as that depends on your situation. Waiting is hard. When a report arrives, add it to your OncoVOIS timeline so it can be read in plain words, and check what the app found.
Is a positive biomarker result good or bad?
A positive or negative result is not good or bad by itself. It only says whether the feature being tested was found. What that means depends on the test, the type of cancer and the stage, and only your oncologist can explain it for you.
Take HER2 as an example. In one situation, a positive result may open the door to particular treatments to discuss. In another, a negative result simply means those treatments are not the focus. For a different test, the meaning could be quite different. That is why you should not compare your result with someone else's. The words positive and negative can also mislead. A positive biomarker result is not the same as a positive test for an infection, and a negative result does not always mean there is nothing to discuss. If a result worries you, write it down and ask your oncologist: what does this result mean for my treatment? The HER2 guide on this site explains HER2 results in more detail.
Do all cancers have biomarker tests?
No, not in the same way. For some cancers, such as certain breast, lung and colon cancers, biomarker testing is a well-known part of planning treatment. For others, fewer biomarkers are currently used, or testing is still mainly part of research.
This is a general picture and it changes as research moves on. Even within one cancer type, which tests are useful can depend on the subtype, the stage and the treatments being discussed. The tests offered can also differ between hospitals. If you want to know which biomarkers are relevant to your cancer, ask your oncologist. OncoVOIS can show tests commonly listed in guidelines for your type of cancer, matched to your reports from a reviewed list and labelled as something to discuss. These are not recommendations, and your oncologist decides which tests you need. If none apply to you, that is an answer your oncologist can give. Ask the doctor to explain why in plain words.